A phase I clinical and pharmacokinetic study of LU 79553 administered every 21 or 42 days in patients (pts) with solid tumors: An EORTC-ECSG study
ANNALS OF ONCOLOGY（1998）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined